1 Lefebvre P (2005) Diabetes yesterday, today and tomorrow. The action of the International Diabetes Federation. Rev Med Liege 60, 273–277.
2 Crespy V & Williamson G (2004) A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134, 3431S–3440S.
3 Islam MS & Choi H (2007) Green tea, anti-diabetic or diabetogenic: a dose response study. Biofactors 29, 45–53.
4 Murase T, Nagasawa A, Suzuki J, et al. (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26, 1459–1464.
5 Rossner S (2002) Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 26, Suppl. 4, S2–S4.
6 Lin JK & Lin-Shiau SY (2006) Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 50, 211–217.
7 Bose M, Lambert JD, Ju J, et al. (2008) The major green tea polyphenol, ( − )-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 1677–1683.
8 Anandh Babu PV, Sabitha KE & Shyamaladevi CS (2006) Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 33, 1184–1189.
9 Klaus S, Pultz S, Thone-Reineke C, et al. (2005) Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 29, 615–623.
10 McKay DL & Blumberg JB (2007) Roles for epigallocatechin gallate in cardiovascular disease and obesity: an introduction. J Am Coll Nutr 26, 362S–365S.
11 Yokozawa T, Nakagawa T & Kitani K (2002) Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 50, 3549–3552.
12 Chen H, Zhang M & Xie B (2005) Components and antioxidant activity of polysaccharide conjugate from green tea. Food Chem 90, 17–21.
13 Cabrera C, Artacho R & Gimenez R (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25, 79–99.
14 Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26, 373S–388S.
15 Harbowy ME & Balentine DA (1997) Tea chemistry. Crit Rev Plant Sci 16, 415–448.
16 Riemersma RA, Rice-Evans CA, Tyrrell RM, et al. (2001) Tea flavonoids and cardiovascular health. QJM 94, 277–282.
17 Sabu MC, Smitha K & Kuttan R (2002) Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 83, 109–116.
18 Das D, Mukherjee S, Mukherjee M, et al. (2005) Aqueous extract of black tea (Camellia sinensis) prevents chronic ethanol toxicity. Curr Sci 88, 952–961.
19 Cooperstien SJ & Walkins D (1981) . In The Islets of Langerhans, pp. 387–390 [Cooperstein SJ and Watkins D, editors]. New York: Academic Press.
20 Csont T, Balogh G, Csonka C, et al. (2002) Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun 290, 1535–1538.
21 Onody A, Csonka C, Giricz Z, et al. (2003) Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 58, 663–670.
22 Trinder P (1969) Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 24–27.
23 Frings CS & Dunn RT (1970) A colorimetric method for determination of total serum lipids based on the sulfo-phospho-vanillin reaction. Am J Clin Pathol 53, 89–91.
24 Doumas BT, Watson WA & Biggs HG (1971) Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31, 87–96.
25 Allain CC, Poon LS, Chan CS, et al. (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20, 470–475.
26 Vikari J (1976) Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest 36, 265–268.
27 Takayama M, Itoh S, Nagasaki T, et al. (1977) A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 79, 93–98.
28 Doumas BT, Bayse DD, Carter RJ, et al. (1981) A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem 27, 1642–1650.
29 McGowan MW, Artiss JD, Strandbergh DR, et al. (1983) A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29, 538–542.
30 Trinder P & Webster D (1984) Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem 21, 430–433.
31 Fossati P, Ponti M, Prencipe L, et al. (1989) One-step protocol for assays of total and direct bilirubin with stable combined reagents. Clin Chem 35, 173–176.
32 Reitman S & Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28, 56–63.
33 Tietz NW, Burtis CA, Duncan P, et al. (1983) A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem 29, 751–761.
34 Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
35 Turner JR & Thayer JF (editors) (2001) Introduction to Analysis of Variance: Design, Analysis and Interpretation. Thousand Oaks, CA: Sage Publications.
36 Moram GS (2001) Effect of aqueous extracts from some plants on alloxan – diabetic rats. Egypt J Hosp Med 2, 57–69.
37 Ene AC, Nwankwo EA & Samdi LM (2007) Alloxan-induced diabetes in rats and the effects of black caraway (Carum carvi L.) oil on their body weight. Res J Med Med Sci 2, 48–52.
38 Czako L, Szabolcs A, Vajda A, et al. (2007) Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats. Eur J Pharmacol 572, 74–81.
39 Butler J, Rodondi N, Zhu Y, et al. (2006) Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 47, 1595–1602.
40 Knuiman MW, Hung J, Divitini ML, et al. (2009) Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prev Rehabil 16, Suppl. 2, 235–241.
41 Thorn LM, Forsblom C, Waden J, et al. (2009) Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 32, Suppl. 5, 950–952.
42 Shimizu M, Kobayashi Y, Suzuki M, et al. (2000) Regulation of intestinal glucose transport by tea catechins. Biofactors 13, 61–65.
43 Kim MJ, Ryu GR, Chung JS, et al. (2003) Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26, 292–299.
44 Janle EM, Portocarrero C, Zhu Y, et al. (2005) Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother 5, 55–65.
45 Zhou X, Wang D, Sun P, et al. (2007) Effects of soluble tea polysaccharides on hyperglycemia in alloxan-diabetic mice. J Agric Food Chem 55, 5523–5528.
46 Waltner-Law ME, Wang XL, Law BK, et al. (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933–34940.
47 Chemler JA, Lock LT, Koffas MA, et al. (2007) Standardized biosynthesis of flavan-3-ols with effects on pancreatic β-cell insulin secretion. Appl Microbiol Biotechnol 77, 797–807.
48 Wolfram S, Raederstorff D, Preller M, et al. (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136, 2512–2518.
49 Kuo KL, Weng MS, Chiang CT, et al. (2005) Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J Agric Food Chem 53, 480–489.
50 Matsumoto N, Okushio K & Hara Y (1998) Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 44, Suppl. 2, 337–342.
51 Yang TT & Koo MW (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 66, 411–423.
52 Bursill CA, Abbey M & Roach PD (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193, 86–93.
53 Lin CL, Huang HC & Lin JK (2007) Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res 48, 2334–2343.
54 Oyejide OO & Olushola L (2005) Hepatoprotective and antioxidant properties of extract of Carmellia sinensis (black tea) in rats. Afr J Biotechnol 4, 1432–1438.
55 Raederstorff DG, Schlachter MF, Elste V, et al. (2003) Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14, 326–332.
56 Koo SI & Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18, 179–183.
57 Chan PT, Fong WP, Cheung YL, et al. (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 129, 1094–1101.
58 Yee WL, Wang Q, Agdinaoay T, et al. (2002) Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Mol Cell Biochem 229, 85–92.
59 Balentine DA, Wiseman SA & Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37, 693–704.
60 Keith RP, Michael JCR & Karen AB (1998) Flavonol glycoside content and composition of tea infusions made from commercially available teas and tea products. J Agric Food Chem 46, Suppl. 7, 2517–2522.
61 Leung LK, Su Y, Chen R, et al. (2001) Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 131, 2248–2251.
62 Taylor EB, Ellingson WJ, Lamb JD, et al. (2005) Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am J Physiol Endocrinol Metab 288, E1055–E1061.
63 Murase T, Misawa K, Haramizu S, et al. (2009) Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 78, 78–84.
64 Lin CL & Lin JK (2008) Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 52, 930–939.
65 Steele VE, Kelloff GJ, Balentine D, et al. (2000) Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 21, 63–67.